Navix Diagnostix, Inc.

Navix Diagnostix, Inc., a for-profit diagnostic services provider headquartered in Taunton, Massachusetts, has maintained a presence in federal procurement since its SAM.gov registration in 2001. The company specializes in providing vascular laboratory services and accreditation support to federal healthcare organizations, with a primary focus on supporting the U.S. Department of Veterans Affairs. Through its federal contracting relationships, Navix Diagnostix has established itself as a specialized vendor capable of delivering critical diagnostic services that enable the Veterans Health Administration to maintain healthcare delivery standards across multiple service regions.

Navix Diagnostix, Inc. has executed multiple delivery order contracts with the Department of Veterans Affairs Veterans Integrated Service Network 17 (VISN 17) for vascular laboratory services and accreditation. These delivery orders have been awarded without small business set-aside designations and have ranged in value from $185,789.36 to $215,742.40, with performance locations primarily in Texas, including Temple, Duncanville, and Dallas. The delivery orders represent fixed-price contracts with economic price adjustment mechanisms, providing flexibility in pricing while maintaining cost certainty for the VA. The company's contract performance has extended consistently from September 2022 through December 2026, with completion dates aligned to annual contract periods, demonstrating sustained engagement and renewal of work through the VA's indefinite delivery contract framework. All awards have been issued by VISN 17, reflecting the regional nature of this contracting relationship and the company's established capability in serving the Texas veteran population across multiple VA healthcare facilities.

Navix Diagnostix, Inc. holds two Indefinite Delivery Contracts awarded by the Department of Veterans Affairs Veterans Integrated Service Network 17, both designated as total small business set-asides. The first IDC, awarded on September 23, 2022, carries a ceiling value of $843,406.40 with a performance period extending through December 11, 2026, and has generated four delivery orders totaling approximately $810,998.54 in executed work. The second IDC, awarded on August 19, 2022, carries a ceiling value of $991,520 with an estimated completion date of August 24, 2022. Both indefinite delivery contracts establish frameworks for the VA to issue delivery orders on an as-needed basis for vascular laboratory services and accreditation support across the VISN 17 service region. These IDV vehicles enable the Veterans Health Administration to maintain continuous vascular laboratory service capacity and accreditation compliance across multiple healthcare facilities, supporting the agency's core mission to provide quality healthcare to American veterans. The sustained issuance of delivery orders under these indefinite delivery contracts, particularly the active contract extending through 2026, indicates the VA's ongoing reliance on Navix Diagnostix as a critical vendor for specialized diagnostic services within the Texas service area.